Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
Preprints are the future but peer review is still king' - Research Professional News
Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility - The Lancet Global Health
Flawed preprint based on autopsies inadequate to demonstrate that COVID-19 vaccines caused 74% of those deaths - Health Feedback
Preprints with The Lancet: joining online research discussion platforms - The Lancet
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
The Lancet Global Health Home Page
The Lancet Digital Health
Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study - eBioMedicine
The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8 COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg https://t.co/pT8lBAWS4g" / X
How swamped preprint servers are blocking bad coronavirus research
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil - The Lancet
For Authors: Submit your work
Robustness of evidence reported in preprints during peer review - The Lancet Global Health
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review - eClinicalMedicine
A new paradigm is needed to explain long COVID - The Lancet Respiratory Medicine
The Lancet Respiratory Medicine Home Page
Many scientists citing two scandalous COVID-19 papers ignore their retractions | Science | AAAS
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis - The Lancet
The Lancet Infectious Diseases, January 2024, Volume 24, Issue 1, Pages 1-106, e1-e69
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet Infectious Diseases
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
